CDKN2A and acute lymphoblastic leukemia: Deletions in cyclin-dependent kinase inhibitor 2A (CDKN2A) locus is a common mutation in T-ALL; so, CDKN2A tumor suppressor locus is disrupted in 90% of T-ALL cases (Table 1) (64, 65).